NCT03223311View on ClinicalTrials.gov

"Percutaneous Axillary Access in the Endovascular Treatment of Thoracoabdominal Aortic Pathology (PAXA)"

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions

Thoracoabdominal Aortic Aneurysm

Trial Locations (1)

20132

San Raffaele Hospital, Milan

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT03223311 - "Percutaneous Axillary Access in the Endovascular Treatment of Thoracoabdominal Aortic Pathology (PAXA)" | Biotech Hunter | Biotech Hunter